Brain imaging in urea cycle disorders

Molecular Genetics and Metabolism

Volumn 100, Issue SUPPL., 2010, Pages

  Gropman, Andrea ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Biomarkers; DTI; fMRI; Hyperammonemia; MRI; MRS; Neuroimaging; Urea cycle

Indexed keywords

AMMONIA; BIOLOGICAL MARKER; ORNITHINE CARBAMOYLTRANSFERASE; UREA;

BIOACCUMULATION; BIOSYNTHESIS; BRAIN EDEMA; BRAIN INJURY; CARBON NUCLEAR MAGNETIC RESONANCE; COGNITION; COGNITIVE DEFECT; COMA; DETOXIFICATION; DIFFUSION TENSOR IMAGING; DISEASE SEVERITY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HYPERAMMONEMIA; INBORN ERROR OF METABOLISM; INTELLECTUAL IMPAIRMENT; LIVER DYSFUNCTION; METABOLIC DISORDER; MORBIDITY; MORTALITY; NEUROANATOMY; NEUROIMAGING; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RARE DISEASE; RECURRENT DISEASE; REVIEW; SURVIVAL; UREA CYCLE DISORDER; WHITE MATTER; WORKING MEMORY;

BRAIN; BRAIN MAPPING; COGNITION DISORDERS; DIFFUSION TENSOR IMAGING; HUMANS; UREA CYCLE DISORDERS, INBORN; WATER-ELECTROLYTE IMBALANCE;

EID: 77950339042     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2010.01.017     Document Type: Review

References (61)

1. Summar M.L., Dobbelaere D., Brusilow S., and Lee B. Diagnosis, symptoms, frequency and mortality of 260 patients with urea cycle disorders from a 21-year, multicentre study of acute hyperammonaemic episodes. Acta Paediatr. 97 (2008) 1420-1425
2. Msall M., Batshaw M.L., Suss R., Brusilow S.W., and Mellits E.D. Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies. N. Engl. J. Med. 310 (1984) 1500-1505
3. Breningstall G.N. Neurologic syndromes in hyperammonemic disorders. Pediatr. Neurol. 2 (1986) 253-262
4. Nicolaides P., Liebsch D., Dale N., Leonard J., and Surtees R. Neurological outcome of patients with ornithine carbamoyltransferase deficiency. Arch. Dis. Child. 86 (2002) 54-56
5. Enns G.M., Berry S.A., Berry G.T., Rhead W.J., Brusilow S.W., and Hamosh A. Survival after treatment with phenylacetate and benzoate for urea-cycle disorders. N. Engl. J. Med. 356 (2007) 2282-2292
6. Bachmann C. Long-term outcome of patients with urea cycle disorders and the question of neonatal screening. Eur. J. Pediatr. 162 suppl. 1 (2003) S29-S33
7. Bachmann C. Ornithine carbamoyl transferase deficiency: findings, models and problems. J. Inherit. Metab. Dis. 15 (1992) 578-591
8. Picca S., Dionisi-Vici C., Abeni D., Pastore A., Rizzo C., Orzalesi M., Sabetta G., Rizzoni G., and Bartuli A. Extracorporeal dialysis in neonatal hyperammonemia: modalities and prognostic indicators. Pediatr. Nephrol. 16 (2001) 862-867
9. Uchino T., Endo F., and Matsuda I. Neurodevelopmental outcome of long-term therapy of urea cycle disorders in japan. J. Inherit. Metab. Dis. 21 suppl. 1 (1998) 151-159
10. Msall M., Monahan P.S., Chapanis N., and Batshaw M.L. Cognitive development in children with inborn errors of urea synthesis. Acta Paediatr. Jpn. 30 (1988) 435-441
11. Gropman A.L., and Batshaw M.L. Cognitive outcome in urea cycle disorders. Mol. Genet. Metab. 81 suppl. 1 (2004) S58-S62
12. Drogari E., and Leonard J.V. Late onset ornithine carbamoyl transferase deficiency in males. Arch. Dis. Child. 63 (1988) 1363-1367
13. Batshaw M.L., Roan Y., Jung A.L., Rosenberg L.A., and Brusilow S.W. Cerebral dysfunction in asymptomatic carriers of ornithine transcarbamylase deficiency. N. Engl. J. Med. 302 (1980) 482-485
14. Christodoulou J., Qureshi I.A., McInnes R.R., and Clarke J.T. Ornithine transcarbamylase deficiency presenting with strokelike episodes. J. Pediatr. 122 (1993) 423-425
15. DiMagno E.P., Lowe J.E., Snodgrass P.J., and Jones J.D. Ornithine transcarbamylase deficiency-a cause of bizarre behavior in a man. N. Engl. J. Med. 315 (1986) 744-747
16. Gaspari R., Arcangeli A., Mensi S., Wismayer D.S., Tartaglione T., Antuzzi D., Conti G., and Proietti R. Late-onset presentation of ornithine transcarbamylase deficiency in a young woman with hyperammonemic coma. Ann. Emerg. Med. 41 (2003) 104-109
17. Mizoguchi K., Sukehiro K., Ogata M., Onizuka S., Watanabe J., Yoshida I., and Yoshino M. A case of ornithine transcarbamylase deficiency with acute and late onset simulating reye's syndrome in an adult male. Kurume Med. J. 37 (1990) 105-109
18. Perini M., Zarcone D., and Corbetta C. Hyperammoniemic coma in an adolescent girl: an unusual case of ornithine transcarbamylase deficiency. Ital. J. Neurol. Sci. 14 (1993) 461-464
19. Rimbaux S., Hommet C., Perrier D., Cottier J.P., Legras A., Labarthe F., Lemarcis L., Autret A., and Maillot F. Adult onset ornithine transcarbamylase deficiency: an unusual cause of semantic disorders. J. Neurol. Neurosurg. Psychiatry 75 (2004) 1073-1075
20. Gyato K., Wray J., Huang Z.J., Yudkoff M., and Batshaw M.L. Metabolic and neuropsychological phenotype in women heterozygous for ornithine transcarbamylase deficiency. Ann. Neurol. 55 (2004) 80-86
21. Gropman A.L., Fricke S.T., Seltzer R.R., Hailu A., Adeyemo A., Sawyer A., van Meter J., Gaillard W.D., McCarter R., Tuchman M., and Batshaw M. 1H MRS identifies symptomatic and asymptomatic subjects with partial ornithine transcarbamylase deficiency. Mol. Genet. Metab. 95 (2008) 21-30
22. Felipo V., and Butterworth R.F. Neurobiology of ammonia. Prog. Neurobiol. 67 (2002) 259-279
23. Ott P., Clemmesen O., and Larsen F.S. Cerebral metabolic disturbances in the brain during acute liver failure: from hyperammonemia to energy failure and proteolysis. Neurochem. Int. 47 (2005) 13-18
24. Willard-Mack C.L., Koehler R.C., Hirata T., Cork L.C., Takahashi H., Traystman R.J., and Brusilow S.W. Inhibition of glutamine synthetase reduces ammonia-induced astrocyte swelling in rat. Neuroscience 71 (1996) 589-599
25. Norenberg M.D., Rao K.V., and Jayakumar A.R. Mechanisms of ammonia-induced astrocyte swelling. Metab. Brain Dis. 20 (2005) 303-318
26. Takahashi H., Koehler R.C., Brusilow S.W., and Traystman R.J. Inhibition of brain glutamine accumulation prevents cerebral edema in hyperammonemic rats. Am. J. Physiol. 261 (1991) H825-H829
27. Takahashi H., Koehler R.C., Brusilow S.W., and Traystman R.J. Glutamine synthetase inhibition prevents cerebral oedema during hyperammonemia. Acta Neurochir. Suppl. (Wien) 51 (1990) 346-347
28. Batshaw M.L., Brusilow S., Waber L., Blom W., Brubakk A.M., Burton B.K., Cann H.M., Kerr D., Mamunes P., Matalon R., Myerberg D., and Schafer I.A. Treatment of inborn errors of urea synthesis: activation of alternative pathways of waste nitrogen synthesis and excretion. N. Engl. J. Med. 306 (1982) 1387-1392
29. Harding B.N., Leonard J.V., and Erdohazi M. Ornithine carbamoyl transferase deficiency: a neuropathological study. Eur. J. Pediatr. 141 (1984) 215-220
30. Kornfeld M., Woodfin B.M., Papile L., Davis L.E., and Bernard L.R. Neuropathology of ornithine carbamyl transferase deficiency. Acta Neuropathol. 65 (1985) 261-264
31. Dolman C.L., Clasen R.A., and Dorovini-Zis K. Severe cerebral damage in ornithine transcarbamylase deficiency. Clin. Neuropathol. 7 (1988) 10-15
32. Connelly A., Cross J.H., Gadian D.G., Hunter J.V., Kirkham F.J., and Leonard J.V. Magnetic resonance spectroscopy shows increased brain glutamine in ornithine carbamoyl transferase deficiency. Pediatr. Res. 33 (1993) 77-81
33. Takanashi J., Barkovich A.J., Cheng S.F., Kostiner D., Baker J.C., and Packman S. Brain mr imaging in acute hyperammonemic encephalopathy arising from late-onset ornithine transcarbamylase deficiency. AJNR Am. J. Neuroradiol. 24 (2003) 390-393
34. Takanashi J., Kurihara A., Tomita M., Kanazawa M., Yamamoto S., Morita F., Ikehira H., Tanada S., and Kohno Y. Distinctly abnormal brain metabolism in late-onset ornithine transcarbamylase deficiency. Neurology 59 (2002) 210-214
35. Robinson M.B., Hopkins K., Batshaw M.L., McLaughlin B.A., Heyes M.P., and Oster-Granite M.L. Evidence of excitotoxicity in the brain of the ornithine carbamoyltransferase deficient sparse fur mouse. Brain Res. Dev. Brain Res. 90 (1995) 35-44
36. Kruse E., Uehlein N., and Kaldenhoff R. The aquaporins. Genome Biol. 7 (2006) 206
37. Yang B., Zador Z., and Verkman A.S. Glial cell aquaporin-4 overexpression in transgenic mice accelerates cytotoxic brain swelling. J. Biol. Chem. 283 (2008) 15280-15286
38. Lichter-Konecki U., Mangin J.M., Gordish-Dressman H., Hoffman E.P., and Gallo V. Gene expression profiling of astrocytes from hyperammonemic mice reveals altered pathways for water and potassium homeostasis in vivo. Glia 56 (2008) 365-377
39. Krivitzky L., Babikian T., Lee H.S., Thomas N.H., Burk-Paull K.L., and Batshaw M.L. Intellectual, adaptive, and behavioral functioning in children with urea cycle disorders. Pediatr. Res. 66 (2009) 96-101
40. King J.A., Colla M., Brass M., Heuser I., and von Cramon D. Inefficient cognitive control in adult adhd: evidence from trial-by-trial stroop test and cued task switching performance. Behav. Brain Funct. 3 (2007) 42
41. Mirsky A.F. Behavioral and psychophysiological markers of disordered attention. Environ. Health Perspect. 74 (1987) 191-199
42. Gropman A.L. Expanding the diagnostic and research toolbox for inborn errors of metabolism: the role of magnetic resonance spectroscopy. Mol. Genet. Metab. 86 (2005) 2-9
43. Kim K.W., MacFall J.R., and Payne M.E. Classification of white matter lesions on magnetic resonance imaging in elderly persons. Biol. Psychiatry 64 (2008) 273-280
44. Basser P.J., Mattiello J., and LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophys, J. 66 (1994) 259-267
45. Bendlin B.B., Ries M.L., Lazar M., Alexander A.L., Dempsey R.J., Rowley H.A., Sherman J.E., and Johnson S.C. Longitudinal changes in patients with traumatic brain injury assessed with diffusion-tensor and volumetric imaging. Neuroimage 42 (2008) 503-514
46. Li K., Guo L., Nie J., Li G., and Liu T. Review of methods for functional brain connectivity detection using fMRI. Comput. Med. Imaging Graph. 33 (2009) 131-139
47. Nakamura T., Hillary F.G., and Biswal B.B. Resting network plasticity following brain injury. PLoS One 4 12 (2010) e8220
48. Qureshi I.A., and Rao K.V. Sparse-fur (spf) mouse as a model of hyperammonemia: alterations in the neurotransmitter systems. Adv. Exp. Med. Biol. 420 (1997) 143-158
49. Bachmann C., and Colombo J.P. Increase of tryptophan and 5-hydroxyindole acetic acid in the brain of ornithine carbamoyltransferase deficient sparse-fur mice. Pediatr. Res. 18 (1984) 372-375
50. Butterworth R.F. Effects of hyperammonaemia on brain function. J. Inherit. Metab. Dis. 21 suppl. 1 (1998) 6-20
51. Watanabe A., Shiota T., Takei N., and Nagashima H. Excitatory and inhibitory amino acid neurotransmitters and ammonia metabolism in hepatic failure rats. Res. Exp. Med. (Berl.) 185 (1985) 399-404
52. Kreis R., Ross B.D., Farrow N.A., and Ackerman Z. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 182 (1992) 19-27
53. Ross B.D., Jacobson S., Villamil F., Korula J., Kreis R., Ernst T., Shonk T., and Moats R.A. Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities. Radiology 193 (1994) 457-463
54. Provencher S.W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn. Reson. Med. 30 (1993) 672-679
55. Yudkoff M., Daikhin Y., Nissim I., Jawad A., Wilson J., and Batshaw M. In vivo nitrogen metabolism in ornithine transcarbamylase deficiency. J. Clin. Invest. 98 (1996) 2167-2173
56. Gropman A.L., Seltzer R.R., Yudkoff M., Sawyer A., VanMeter J., and Fricke S.T. 1H MRS allows brain phenotype differentiation in sisters with late onset ornithine transcarbamylase deficiency (OTCD) and discordant clinical presentations. Mol. Genet. Metab. 94 (2008) 52-60
57. Westergaard N., Sonnewald U., and Schousboe A. Metabolic trafficking between neurons and astrocytes: the glutamate/glutamine cycle revisited. Dev. Neurosci. 17 (1995) 203-211
58. Blüml S., Moreno-Torres A., and Ross B.D. [1-13C] glucose MRS in chronic hepatic encephalopathy in man. Magn. Reson. Med. 45 (2001) 981-993
59. Gropman A.L., Sailasuta N., Harris K.C., Abulseoud O., and Ross B.D. Ornithine transcarbamylase deficiency with persistent abnormality in cerebral glutamate metabolism in adults. Radiology 252 (2009) 833-841
60. Sailasuta N., Robertson L.W., Harris K.C., Gropman A.L., Allen P.S., and Ross B.D. Clinical NOE 13C MRS for neuropsychiatric disorders of the frontal lobe. J. Magn. Reson. 195 (2008) 219-225
61. Oldham M.S., VanMeter J.W., Shattuck K.F., Cederbaum S.D., and Gropman A.L. Diffusion tensor imaging in arginase deficiency reveals damage to corticospinal tracts. Pediatr. Neurol. 42 (2010) 49-52